As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
We are very excited to launch our new website! Please take a few moments to click around and explore...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
The COVID-19 pandemic has unveiled the huge challenges and risks health workers are facing globally ...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...